The DOI matches its Crossref record; 1,858 of the 1,862 references it cites were found in a registry or an index.
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME
Open accessAbstract
This review encompasses the most important advances in liver functions and hepatotoxicity and analyzes which mechanisms can be studied in vitro. In a complex architecture of nested, zonated lobules, the liver consists of approximately 80 % hepatocytes and 20 % non-parenchymal cells, the latter being involved in a secondary phase that may dramatically aggravate the initial damage. Hepatotoxicity, as well as hepatic metabolism, is controlled by a set of nuclear receptors (including PXR, CAR, HNF-4α, FXR, LXR, SHP, VDR and PPAR) and signaling pathways. When isolating liver cells, some pathways are activated, e.g., the RAS/MEK/ERK pathway, whereas others are silenced (e.g. HNF-4α), resulting in up- and downregulation of hundreds of genes. An understanding of these changes is crucial for a correct interpretation of in vitro data. The possibilities and limitations of the most useful liver in vitro systems are summarized, including three-dimensional culture techniques, co-cultures with non-parenchymal cells, hepatospheres, precision cut liver slices and the isolated perfused liver. Also discussed is how closely hepatoma, stem cell and iPS cell-derived hepatocyte-like-cells resemble real hepatocytes. Finally, a summary is given of the state of the art of liver in vitro and mathematical modeling systems that are currently used in the pharmaceutical industry with an emphasis on drug metabolism, prediction of clearance, drug interaction, transporter studies and hepatotoxicity. One key message is that despite our enthusiasm for in vitro systems, we must never lose sight of the in vivo situation. Although hepatocytes have been isolated for decades, the hunt for relevant alternative systems has only just begun.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures








![Fig. 9 Antiproteolytic effect of acetaldehyde in the single pass perfused rat liver. a Acetaldehyde (5 mmol/l) was infused into the perfused liver for 30 min, and the release of [3H]leucine from pre-labeled rats was taken as a measure of proteolysis. b The resulting inhibition of proteolysis under steady-state conditions at different concentrations of acetaldehyde. Data are from 2 to 4 different experiments and are given as mean ± SEM. From vom Dahl and Häussinger (1998)](/paper-figures/2844bb4a493e46429af445399835e22f/recent-advances-in-2d-and-3d-in-vitro-systems-using-primary-hepatocytes-figure-9.jpg)
















































Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Already in the first few days of cultivation, a reduction of hepatic functions can be observed, e.g. production of plasma proteins, drug metabolizing enzyme activities, glucose metabolism and urea synthesis (Godoy et al., 2013[15]).”
From Optimization of extracellular matrix for primary human hepatocyte cultures using mixed collagen-matrigel matrices (2023) · cites this paper as Godoy et al., 2013[15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Primary human hepatocytes (PHHs) are an important tool for studying human liver disease and drug-induced liver injury (DILI), with other models, such as rat hepatocytes, hepatic cell lines and stem cell-derived hepatocyte-like cells failing to offer metabolically competent and species-relevant alternatives (Godoy et al. 2013).”
From Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile (2017) · cites this paper as Godoy et al. 2013
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In fact, zonation appears to be a large influencing factor on variation during culture as our pathway analysis of the most variable proteins revealed significant association with ketogenesis, cholesterol biosynthesis, fatty acid β oxidation and glutamine synthesis (table S4), all of these are related to the portocentral axis gradient of the lobule (Godoy et al. 2013).”
From Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile (2017) · cites this paper as Godoy et al. 2013
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“although cytotoxicity measures are fundamental in the assessment of a drug’s potential for hepatotoxicity in vitro33,34, gene expression and various phenotypic changes can occur at much lower concentrations35,36.”
From Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology (2022) · cites this paper as [34]
The cited source says what the claim attributes to it.
In the citing paper
“The apical membrane is equipped with transport proteins that eliminate bile acids and xenobiotics from the cell, like multidrug resistance-associated protein 2 (MRP2) (Godoy et al., 2013[15]; Ito et al., 2005[20]).”
From Optimization of extracellular matrix for primary human hepatocyte cultures using mixed collagen-matrigel matrices (2023) · cites this paper as Godoy et al., 2013[15]
The cited source says what the claim attributes to it.
In the citing paper
“The hepatocyte's basal membrane faces the sinusoid. It expresses several transmembrane transporters that manage the exchange of substances with the sinusoidal blood stream (Godoy et al., 2013[15]).”
From Optimization of extracellular matrix for primary human hepatocyte cultures using mixed collagen-matrigel matrices (2023) · cites this paper as Godoy et al., 2013[15]
The cited source says what the claim attributes to it.
In the citing paper
“In vivo, the distribution of ECM components varies between the different parts of the liver acinus, the smallest organizational unit of the liver (Godoy et al., 2013[15]; Martinez-Hernandez and Amenta, 1993[26]).”
From Optimization of extracellular matrix for primary human hepatocyte cultures using mixed collagen-matrigel matrices (2023) · cites this paper as Godoy et al., 2013[15]
The cited source says what the claim attributes to it.
In the citing paper
“The application of primary human hepatocytes following isolation from human tissue is well accepted to be compromised by the process of dedifferentiation.”
From Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile (2017) · cites this paper as Godoy et al. 2013
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In practice, strategies for optimizing HepG2 can be divided into several approaches. The first approach is based on genetic modification of cells to express key biotransformation enzymes, in particular cytochrome P450 isoforms [109]. The second approach involves epigenetic and cultural maturation of cells, which allows for increased expression of nuclear receptors and, consequently, of xenobiotic”
From The HepG2 Cell Line as a Model for Studying Metabolic Dysfunction-Associated Steatotic Liver Disease (2026) · cites this paper as [163]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Wheat proteins improve cryopreservation of rat hepatocytes
Grondin, M., Hamel, F., Averill‐Bates, D. A., & Sarhan, F. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22270 · Cited by 18
RetractedBartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Computer Simulation of Liquids
Allen, M. P., & Tildesley, D. J. (2017) · doi:10.1093/oso/9780198803195.001.0001 · Cited by 20,945
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Computer Simulation of Liquids
P, S., & J, K. (1988) · Journal of Molecular Liquids · doi:10.1016/0167-7322(88)80022-9 · Cited by 16,088
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,673
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay‐Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,320
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Two-photon laser scanning fluorescence microscopy
Denk, W., Strickler, J. H., & Webb, W. W. (1990) · Science · doi:10.1126/science.2321027 · Cited by 9,488
Research works printed but not linked: 9
- Bode JG (2011) Inflammation and liver regeneration. In: Häussinger D (ed) Liver regneration. DeGruyter Verlag, Berlin
- Bücher T, Sies H (1976) Mitochondrial and cytosolic redox states in perfused rat liver: methods and problems in metabolic compartmentation. In: Tager jm WJ, Söling D (eds) Use of isolated liver cells and kidney tubules in metabolic studies. North Holland Publishing Company/American Elsevier, New York/Amsterdam
- EPA (2012) EPA’s reanalysis of key issues related to dioxin toxicity and response to NAS Comments. Environmental Protection Agency (EPA), Washington, DC
- Hallifax D, Foster JA, Houston JB (2010) Prediction of human metabolic clearance from in vitro systems: retrospective analysis and prospective view. Pharm Res 27:2150–2161 · DOI
- ITC (International Transporter Consortium) (2010) Membrane transporters in drug development (Report from the FDA Critical Path Workshop). Nat Rev Drug Discov 9:215–236 · DOI · Paper page
- Lamers W, Moorman A, Charles R (1989) The metabolic lobulus, a key to the architecture of the liver. In: Revisiones Sobre Biologia Celular, Springer, New York
- Sahin S (2003) Perfused liver preparation and its applications. FABAD J Pharm Sci 28:39–49
- Waddington CH (1942) The epigenotype. Endeavour 1:18–20
- Warburg O (1923) Versuche an überlebendem Karzinomgewebe. Biochem Z 142:317
Cited by
Sorted by citations
Items 301–400 of 1,002
Zou, Y., Xiong, J.-B., Ma, K., Wang, A., & Qian, K. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.07.074 · Cited by 41
Metabolomics profiling of steatosis progression in HepaRG ® cells using sodium valproate
Cuykx, M., Claes, L., Rodrigues, R. M., Vanhaecke, T., & Covaci, A. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2017.12.015 · Cited by 41
Self-citationUnzu, C., Planet, E., Brandenberg, N., Fusil, F., Cassano, M., Pérez‐Vargas, J., Friedli, M., Cosset, F., Lütolf, M. P., Wildhaber, B. E., et al. (2018) · Hepatology · doi:10.1002/hep.30425 · Cited by 41
In Vitro Models of the Liver: Disease Modeling, Drug Discovery and Clinical Applications
Collins, S. D., Yuen, G., Tu, T., Budzinska, M. A., Spring, K. J., Bryant, K., & Shackel, N. A. (2019) · Codon Publications eBooks · doi:10.15586/hepatocellularcarcinoma.2019.ch3 · Cited by 42
A comparison of hepato-cellular in vitro platforms to study CYP3A4 induction
Bulutoglu, B., Rey-Bedón, C., Mert, S., Tian, L., Jang, Y.-Y., Yarmush, M. L., & Usta, O. B. (2020) · PLOS ONE · doi:10.1371/journal.pone.0229106 · Cited by 41
A liver-on-a-chip for hepatoprotective activity assessment
Deng, J., Cong, Y., Han, X., Wei, W., Lu, Y., Liu, T., Zhao, W., Lin, B., Luo, Y., & Zhang, X. (2020) · Biomicrofluidics · doi:10.1063/5.0024767 · Cited by 41
Delivery of synthetic mRNAs for tissue regeneration
Steinle, H., Weber, M., Stoppelkamp, S., Große‐Berkenbusch, K., Golombek, S., Weber, M., Çanak-Ipek, T., Trenz, S.-M., Schlensak, C., & Avci‐Adali, M. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114007 · Cited by 42
Hengstler, J. G., Sjogren, A.-K. M., Zink, D., & Hornberg, J. J. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02669-7 · Cited by 41
Self-citationJian, H., Li, X., Dong, Q., Tian, S., & Bai, S. (2023) · Cell Proliferation · doi:10.1111/cpr.13465 · Cited by 40
Organoid-guided precision hepatology for metabolic liver disease
Osonoi, S., & Takebe, T. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.01.002 · Cited by 40
Liver-on-chips for drug discovery and development
Mehta, V., Karnam, G., & Madgula, V. L. M. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101143 · Cited by 41
Yang, X., Weng, Z., Mendrick, D. L., & Shi, Q. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.01.013 · Cited by 40
Keller, R., Klein, M., Thomas, M., Dräger, A., Metzger, U., Templin, M. F., Joos, T. O., Thasler, W. E., Zell, A., & Zanger, U. M. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004431 · Cited by 42
Self-citationKang, S. J., Lee, H.-M., Park, Y.-I., Yi, H., Lee, H., So, B., Song, J., & Kang, H. (2016) · Cell Biology and Toxicology · doi:10.1007/s10565-016-9342-0 · Cited by 41
Zetterberg, C., Maltais, F., Laitinen, L., Liao, S., Tsao, H., Chakilam, A., & Hariparsad, N. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.071100 · Cited by 40
Drug Transporter Expression and Activity in Human Hepatoma HuH-7 Cells
Jouan, E., Vée, M. L., Denizot, C., Parmentier, Y., & Fardel, O. (2016) · Pharmaceutics · doi:10.3390/pharmaceutics9010003 · Cited by 42
Ancuceanu, R., Hovaneț, M. V., Anghel, A. I., Furtunescu, F., Neagu, M. T., Constantin, C., & Dinu, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062114 · Cited by 45
Applications of the microphysiology systems database for experimental ADME-Tox and disease models
Schurdak, M. E., Vernetti, L. A., Bergenthal, L., Wolter, Q. K., Shun, T. Y., Karcher, S. C., Taylor, D. L., & Gough, A. (2020) · Lab on a Chip · doi:10.1039/c9lc01047e · Cited by 41
Sakolish, C., Reese, C. E., Luo, Y., Valdiviezo, A., Schurdak, M. E., Gough, A., Taylor, D. L., Chiu, W. A., Vernetti, L. A., & Rusyn, I. (2020) · Toxicology · doi:10.1016/j.tox.2020.152651 · Cited by 41
High-Content Screening for the Detection of Drug-Induced Oxidative Stress in Liver Cells
Donato, M. T., & Tolosa, L. (2021) · Antioxidants · doi:10.3390/antiox10010106 · Cited by 41
Self-citationBarraza, A. D., Finlayson, K. A., Leusch, F. D. L., & van de Merwe, J. P. (2021) · Environmental Pollution · doi:10.1016/j.envpol.2021.117470 · Cited by 40
Rodd, A. L., Messier, N. J., Vaslet, C. A., & Kane, A. B. (2017) · Aquatic Toxicology · doi:10.1016/j.aquatox.2017.02.018 · Cited by 42
Bile canaliculi remodeling activates YAP via the actin cytoskeleton during liver regeneration
Meyer, K., Morales‐Navarrete, H., Seifert, S., Wilsch‐Braeuninger, M., Dahmen, U., Tanaka, E. M., Brusch, L., Kalaidzidis, Y., & Zerial, M. (2020) · Molecular Systems Biology · doi:10.15252/msb.20198985 · Cited by 39
Self-citationVinardell, M. P. (2014) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2014.12.018 · Cited by 39
Parmentier, Y., Pothier, C., Delmas, A., Caradec, F., Trancart, M.-M., Guillet, F., Bouaita, B., Chesné, C., Houston, J. B., & Walther, B. (2016) · Xenobiotica · doi:10.1080/00498254.2016.1208854 · Cited by 39
Self-citationSistare, F. D., Mattes, W. B., & LeCluyse, E. L. (2016) · ILAR Journal · doi:10.1093/ilar/ilw025 · Cited by 39
Self-citationRoles of Hepatic Drug Transporters in Drug Disposition and Liver Toxicity
Pan, G. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-7647-4_6 · Cited by 40
Hepatic Rab24 controls blood glucose homeostasis via improving mitochondrial plasticity
Seitz, S., Kwon, Y., Hartleben, G., Jülg, J., Sekar, R., Krahmer, N., Najafi, B., Loft, A., Gancheva, S., Stemmer, K., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0124-x · Cited by 46
Wild, S. L., Elghajiji, A., Rodriguez, C. G., Weston, S. D., Burke, Z. D., & Tosh, D. (2020) · Genes · doi:10.3390/genes11101163 · Cited by 40
Petrópolis, D. B., Faust, D. M., Jhingan, G. D., & Guillén, N. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004381 · Cited by 39
Rowe, C., Shaeri, M., Large, E. M., Cornforth, T. V., Robinson, A., Kostrzewski, T. M., Sison-Young, R. L. C., Goldring, C. E., Park, K., & Hughes, D. J. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.09.012 · Cited by 39
Self-citationNatural Products for Acetaminophen-Induced Acute Liver Injury: A Review
Li, X., Lao, R., Lei, J., Chen, Y., Zhou, Q., Wang, T., & Tong, Y. (2023) · Molecules · doi:10.3390/molecules28237901 · Cited by 38
Lineage-Specific Regulation of Epigenetic Modifier Genes in Human Liver and Brain
Weng, M. K., Natarajan, K., Scholz, D., Ivanova, V. N., Sachinidis, A., Hengstler, J. G., Waldmann, T., & Leist, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102035 · Cited by 38
Self-citationStarokozhko, V., Vatakuti, S., Schievink, B., Merema, M. T., Asplund, A., Synnergren, J., Aspegren, A., & Groothuis, G. M. M. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1865-x · Cited by 42
Self-citationRobertson, M. J., Soibam, B., O’Leary, J. G., Sampaio, L. C., & Taylor, D. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191892 · Cited by 38
Identification of the Secreted Proteins Originated from Primary Human Hepatocytes and HepG2 Cells
Frankó, A., Hartwig, S., Kotzka, J., Ruoß, M., Nussler, A. K., Königsrainer, A., Häring, H., Lehr, S., & Peter, A. (2019) · Nutrients · doi:10.3390/nu11081795 · Cited by 38
Self-citationKukla, D. A., Crampton, A. L., Wood, D. K., & Khetani, S. R. (2020) · Gene Expression · doi:10.3727/105221620x15868728381608 · Cited by 38
Automatic Liver Segmentation in CT Images with Enhanced GAN and Mask Region‐Based CNN Architectures
Wei, X., Chen, X., Lai, C., Zhu, Y., Yang, H., & Du, Y. (2021) · BioMed Research International · doi:10.1155/2021/9956983 · Cited by 39
Heparin hydrogel sandwich cultures of primary hepatocytes
Foster, E. E., You, J., Siltanen, C. A., Patel, D., Haque, A., Anderson, L., & Revzin, A. (2015) · European Polymer Journal · doi:10.1016/j.eurpolymj.2014.12.033 · Cited by 38
The virtual liver: state of the art and future perspectives
Drasdo, D., Bode, J. G., Dahmen, U., Dirsch, O., Dooley, S., Gebhardt, R., Ghallab, A., Godoy, P., Häussinger, D., Hammad, S., et al. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1384-6 · Cited by 39
Self-citationRecent advances in liver‐on‐chips: Design, fabrication, and applications
Qiu, L., Kong, B., Kong, T., & Wang, H. (2023) · Smart Medicine · doi:10.1002/smmd.20220010 · Cited by 38
Liver dECM–Gelatin Composite Bioink for Precise 3D Printing of Highly Functional Liver Tissues
Kim, M. K., Jeong, W., & Kang, H. (2023) · Journal of Functional Biomaterials · doi:10.3390/jfb14080417 · Cited by 37
How useful are clinical liver function tests in in vitro human hepatotoxicity assays?
Borlak, J. T., Chougule, A., & Singh, P. K. (2014) · Toxicology in Vitro · doi:10.1016/j.tiv.2014.03.006 · Cited by 37
Stem-cell derived hepatocyte-like cells for the assessment of drug-induced liver injury
Donato, M. T., & Tolosa, L. (2019) · Differentiation · doi:10.1016/j.diff.2019.02.004 · Cited by 38
Self-citationInflammation-associated suppression of metabolic gene networks in acute and chronic liver disease
Campos, G., Schmidt‐Heck, W., Smedt, J. D., Widera, A., Ghallab, A., Pütter, L., González, D., Edlund, K., Cadenas, C., Marchan, R., et al. (2020) · Archives of Toxicology · doi:10.1007/s00204-019-02630-3 · Cited by 37
Self-citationCarlessi, R., Köhn‐Gaone, J., Olynyk, J. K., & Tirnitz‐Parker, J. E. E. (2019) · Codon Publications eBooks · doi:10.15586/hepatocellularcarcinoma.2019 · Cited by 39
Organ-on-Chip Models: New Opportunities for Biomedical Research
Mosig, A. S. (2016) · Future Science OA · doi:10.4155/fsoa-2016-0038 · Cited by 39
Human parenchymal and non-parenchymal liver cell isolation, culture and characterization
Damm, G., Pfeiffer, E., Burkhardt, B., Vermehren, J., Nüssler, A. K., & Weiss, T. S. (2013) · Hepatology International · doi:10.1007/s12072-013-9475-7 · Cited by 36
Self-citationden Eede, N. V., Cuykx, M., Rodrigues, R. M., Laukens, K., Neels, H. M., Covaci, A., & Vanhaecke, T. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2015.08.012 · Cited by 36
Self-citationLiu, X., & Hummon, A. B. (2015) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-014-1071-0 · Cited by 38
Sewell, F. R., Aggarwal, M., Bachler, G., Broadmeadow, A., Gellatly, N. L., Moore, E., Robinson, S., Rooseboom, M., Stevens, A. J., Terry, C., et al. (2017) · Toxicology · doi:10.1016/j.tox.2017.07.018 · Cited by 36
Da-silva, F., Boulenc, X., Vermet, H., Compigne, P., Gerbal‐Chaloin, S., Daujat‐Chavanieu, M., Klieber, S., & Poulin, P. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.03.001 · Cited by 36
Fraser, K., Bruckner, D. M., & Dordick, J. S. (2018) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00054 · Cited by 38
Li, B., Li, W., Tian, Y., Guo, S., Qian, L., Xu, D., & Cao, N. (2019) · Biological Trace Element Research · doi:10.1007/s12011-019-01717-3 · Cited by 36
Peptide-based scaffolds for the culture and maintenance of primary human hepatocytes
MacPherson, D., Bram, Y., Park, J., & Schwartz, R. E. (2021) · Scientific Reports · doi:10.1038/s41598-021-86016-5 · Cited by 36
Rajan, S. A. P., Sherfey, J. S., Ohri, S., Nichols, L., Smith, J. T., Parekh, P., Kadar, E. P., Clark, F., George, B. T., Gregory, L., et al. (2023) · The AAPS Journal · doi:10.1208/s12248-023-00870-x · Cited by 35
3D Printing for Liver Tissue Engineering: Current Approaches and Future Challenges
Lewis, P. L., & Shah, R. N. (2016) · Current Transplantation Reports · doi:10.1007/s40472-016-0084-y · Cited by 35
High-content imaging assays on a miniaturized 3D cell culture platform
Joshi, P., Datar, A., Yu, K., Kang, S., & Lee, M. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.02.014 · Cited by 36
Alternatives to animal testing in basic and preclinical research of atopic dermatitis
Löwa, A., Jevtić, M., Gorreja, F., & Hedtrich, S. (2018) · Experimental Dermatology · doi:10.1111/exd.13498 · Cited by 39
Tricot, T., Verfaillie, C. M., & Kumar, M. (2022) · Cells · doi:10.3390/cells11030442 · Cited by 36
A nuclear receptor facilitates differentiation of human PSCs into more mature hepatocytes
Ma, H., de Zwaan, E., Guo, Y. E., Cejas, P., Thiru, P., van de Bunt, M., Jeppesen, J. F., Syamala, S., Dall’Agnese, A., Abraham, B. J., et al. (2022) · Cell stem cell · doi:10.1016/j.stem.2022.03.015 · Cited by 37
Transcriptional Regulation of Solute Carrier Drug Transporters
Zhou, S., & Shu, Y. (2022) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000704 · Cited by 35
Liver-on-a-chip: Considerations, advances, and beyond
Yang, Z., Liu, X., Cribbin, E. M., Kim, A. M., Li, J. J., & Yong, K. (2022) · Biomicrofluidics · doi:10.1063/5.0106855 · Cited by 36
Comparative metabolism of aflatoxin B1 in mouse, rat and human primary hepatocytes using HPLC–MS/MS
Gerdemann, A., Cramer, B., Degen, G. H., Veerkamp, J., Günther, G., Albrecht, W., Behrens, M., Esselen, M., Ghallab, A., Hengstler, J. G., et al. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03607-z · Cited by 34
Self-citationHormone and Drug-Mediated Modulation of Glucose Metabolism in a Microscale Model of the Human Liver
Davidson, M. D., Lehrer, M., & Khetani, S. R. (2014) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2014.0512 · Cited by 34
Terashima, J., Goto, S., Hattori, H., Hoshi, S., Ushirokawa, M., Kudo, K., Habano, W., & Ozawa, S. (2015) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2015.10.001 · Cited by 35
Screening for Chemical Toxicity Using Cryopreserved Precision Cut Lung Slices
Watson, C., Damiani, F., Ram‐Mohan, S., Rodrigues, S., Queiroz, P. D. M., Donaghey, T. C., Lichtenstein, J. H. R., Brain, J. D., Krishnan, R., & Molina, R. M. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv320 · Cited by 34
Arbo, M. D., Melega, S., Stöber, R. M., Schug, M., Rempel, E., Rahnenführer, J., Godoy, P., Reif, R., Cadenas, C., Bastos, M. D. L., et al. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1665-3 · Cited by 35
Self-citationGouliarmou, V., Lostia, A. M., Coecke, S., Bernasconi, C., Bessems, J. G. M., Dorne, J. L. C. M., Ferguson, S., Testai, E., Gundert‐Remy, U., Houston, J. B., et al. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.08.004 · Cited by 36
Self-citationHercog, K., Štampar, M., Štern, A., Filipič, M., & Žegura, B. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.114965 · Cited by 35
Evolution of 3D bioprinting-from the perspectives of bioprinting companies
Ke, D., Niu, C., & Yang, X. (2022) · Bioprinting · doi:10.1016/j.bprint.2022.e00193 · Cited by 37
Telles-Silva, K. A., Pacheco, L. V. B., Komatsu, S., Chianca, F., de Caires-Junior, L. C., Araújo, B. H. S., Goulart, E., & Zatz, M. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.845360 · Cited by 34
Basu, A., Dydowiczová, A., Čtveráčková, L., Jaša, L., Trosko, J. E., Bláha, L., & Babica, P. (2018) · Environmental Science & Technology · doi:10.1021/acs.est.8b02291 · Cited by 34
Terelius, Y., Figler, R. A., Marukian, S., Collado, M. S., Lawson, M. J., Mackey, A. J., Manka, D., Qualls, C. W., Blackman, B. R., Wamhoff, B. R., et al. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.11.023 · Cited by 33
Dambach, D. M., Misner, D., Brock, M., Fullerton, A. M., Proctor, W. R., Maher, J. M., Lee, D. H., Ford, K. A., & Diaz, D. (2015) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5b00396 · Cited by 35
Paper supported long-term 3D liver co-culture model for the assessment of hepatotoxic drugs
Wang, Y., Su, W., Wang, L., Jiang, L., Liu, Y., Hui, L., & Qin, J. (2017) · Toxicology Research · doi:10.1039/c7tx00209b · Cited by 34
Gao, Q., Gu, Y., Jiang, Y., Fan, L., Wei, Z., Jin, H., Yang, X., Wang, L., Li, X., Tai, S., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0595-9 · Cited by 33
Microfluidic Cell Culture Platforms to Capture Hepatic Physiology and Complex Cellular Interactions
Bale, S. S., & Borenstein, J. T. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.083055 · Cited by 36
Primary hepatocytes and their cultures for the testing of drug-induced liver injury
Vilas‐Boas, V., Cooreman, A., Gijbels, E., Campenhout, R. V., Arnesdotter, E., Ballet, S., Annaert, P., Cogliati, B., & Vinken, M. (2018) · Advances in pharmacology · doi:10.1016/bs.apha.2018.08.001 · Cited by 35
Self-citationKermanizadeh, A., Brown, D. M., Moritz, W., & Stone, V. (2019) · Scientific Reports · doi:10.1038/s41598-019-43870-8 · Cited by 33
Liver microsystems in vitro for drug response
Lee, J.-H., Ho, K.-L., & Fan, S.-K. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0575-0 · Cited by 33
Tao, T. P., Brandmair, K., Gerlach, S., Przibilla, J., Géniès, C., Jacques, C., Schepky, A. G., Marx, U., Hewitt, N. J., Maschmeyer, I., et al. (2021) · Journal of Applied Toxicology · doi:10.1002/jat.4146 · Cited by 33
Self-citationPark, C. G., Ryu, C. S., Sung, B., Manz, A., Kong, H., & Kim, Y. J. (2022) · Aquatic Toxicology · doi:10.1016/j.aquatox.2022.106105 · Cited by 33
A call for a Human Exposome Project
Härtung, T. (2023) · ALTEX · doi:10.14573/altex.2301061 · Cited by 42
Clerbaux, L., Paini, A., Lumen, A., Osman‐Ponchet, H., Worth, A. P., & Fardel, O. (2019) · Environment International · doi:10.1016/j.envint.2019.03.003 · Cited by 33
Judging the value of ‘liver-on-a-chip’ devices for prediction of toxicity
Starokozhko, V., & Groothuis, G. M. M. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1246537 · Cited by 33
Self-citationLong-term culture of human liver tissue with advanced hepatic functions
Ng, S. S., Xiong, A., Nguyen, K., Masek, M., No, D. Y., Elazar, M., Shteyer, E., Winters, M. A., Voedisch, A., Shaw, K., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.90853 · Cited by 32
Are zebrafish larvae suitable for assessing the hepatotoxicity potential of drug candidates?
Mesens, N., Crawford, A. D., Menke, A. L., Hung, P. D., Goethem, F. V., Nuyts, R., Hansen, E., Wolterbeek, A. P. M., Gompel, J. V., de Witte, P. A. M., et al. (2015) · Journal of Applied Toxicology · doi:10.1002/jat.3091 · Cited by 32
Dornbos, P., & LaPres, J. J. (2017) · Toxicology · doi:10.1016/j.tox.2017.12.007 · Cited by 32
Wei, G., Wang, J., Lv, Q., Liu, M., Xu, H., Zhang, H., Jin, L., Yu, J., & Wang, X. (2018) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36421 · Cited by 32
Foka, P., Dimitriadis, A., Karamichali, E., Kyratzopoulou, E., Giannimaras, D., Koskinas, J. S., Varaklioti, A., Mamalaki, A., & Georgopoulou, U. (2016) · Virulence · doi:10.1080/21505594.2016.1175700 · Cited by 31
Ethanol sensitizes hepatocytes for TGF-β-triggered apoptosis
Gaitantzi, H., Meyer, C., Rakoczy, P., Thomas, M., Wahl, K., Wandrer, F., Bantel, H., Alborzinia, H., Wölfl, S., Ehnert, S., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0071-y · Cited by 31
Self-citationToxicogenomics directory of rat hepatotoxicants in vivo and in cultivated hepatocytes
Grinberg, M., Stöber, R. M., Albrecht, W., Edlund, K., Schug, M., Godoy, P., Cadenas, C., Marchan, R., Lampen, A., Braeuning, A., et al. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2352-3 · Cited by 31
Self-citationAlcohol Metabolism Potentiates HIV-Induced Hepatotoxicity: Contribution to End-Stage Liver Disease
Ganesan, M., New‐Aaron, M., Dagur, R. S., Makarov, E., Wang, W., Kharbanda, K. K., Kidambi, S., Poluektova, L. Y., & Osna, N. A. (2019) · Biomolecules · doi:10.3390/biom9120851 · Cited by 31
Fabrication of Perfusable Vascular Channels and Capillaries in 3D Liver-like Tissue
Mori, N., Akagi, Y., Imai, Y., Takayama, Y., & Kida, Y. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-62286-3 · Cited by 31
Bartucci, R., van der Meer, A. Z., Boersma, Y. L., Olinga, P., & Salvati, A. L. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-02992-7 · Cited by 31
Self-citation3D Hepatic Organoid-Based Advancements in LIVER Tissue Engineering
Panwar, A., Das, P., & Tan, L. P. (2021) · Bioengineering · doi:10.3390/bioengineering8110185 · Cited by 32
Kalot, R., Mhanna, R., & Talhouk, R. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108156 · Cited by 31
Hughes, D. J., Kostrzewski, T. M., & Sceats, E. L. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217708976 · Cited by 33
Sprouting angiogenesis in engineered pseudo islets
Hospodiuk, M., Dey, M., Ayan, B., Sosnoski, D. M., Moncal, K. K., Wu, Y. B., & Ozbolat, I. T. (2018) · Biofabrication · doi:10.1088/1758-5090/aab002 · Cited by 31
Metadata
- Authors
- Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., Braeuning, A., Budinsky, R. A., Burkhardt, B., Cameron, N. R., Camussi, G., Cho, C.-S., Choi, Y.-J., Craig Rowlands, J., Dahmen, U., Damm, G., Dirsch, O., Donato, M. T., Dong, J., Dooley, S., Drasdo, D., Eakins, R., Ferreira, K. S., Fonsato, V., Fraczek, J., Gebhardt, R., Gibson, A., Glanemann, M., Goldring, C. E. P., Gómez-Lechón, M. J., Groothuis, G. M. M., Gustavsson, L., Guyot, C., Hallifax, D., Hammad, S., Hayward, A., Häussinger, D., Hellerbrand, C., Hewitt, P., Hoehme, S., Holzhütter, H.-G., Houston, J. B., Hrach, J., Ito, K., Jaeschke, H., Keitel, V., Kelm, J. M., Kevin Park, B., Kordes, C., Kullak-Ublick, G. A., LeCluyse, E. L., Lu, P., Luebke-Wheeler, J., Lutz, A., Maltman, D. J., Matz-Soja, M., McMullen, P., Merfort, I., Messner, S., Meyer, C., Mwinyi, J., Naisbitt, D. J., Nussler, A. K., Olinga, P., Pampaloni, F., Pi, J., Pluta, L., Przyborski, S. A., Ramachandran, A., Rogiers, V., Rowe, C., Schelcher, C., Schmich, K., Schwarz, M., Singh, B., Stelzer, E. H. K., Stieger, B., Stöber, R., Sugiyama, Y., Tetta, C., Thasler, W. E., Vanhaecke, T., Vinken, M., Weiss, T. S., Widera, A., Woods, C. G., Xu, J. J., Yarborough, K. M., & Hengstler, J. G.
- Affiliations
- University of Zurich (CH)
- Leibniz Research Centre for Working Environment and Human Factors (DE)
- The Hamner Institutes for Health Sciences (US)
- Goethe University Frankfurt (DE)
- Vrije Universiteit Brussel (BE)
- University of Freiburg (DE)
- Leipzig University (DE)
- Dow Chemical (United States) (US)
- Durham University (GB)
- Seoul National University (KR)
- Instituto de Investigación Sanitaria La Fe (ES)
- Heidelberg University (DE)
- University of Liverpool (GB)
- University of Groningen (NL)
- Lund University (SE)
- University of Manchester (GB)
- South Valley University (EG)
- Heinrich Heine University Düsseldorf (DE)
- University Hospital Regensburg (DE)
- Merck KGaA, Darmstadt (Germany) (DE)
- Charité – Universitätsmedizin Berlin (DE)
- Musashino University (JP)
- University Hospital Zurich (CH)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Corresponding author
- Hewitt, Nicola J.
- ORCID
- Hewitt, Nicola J.
- Andersen, Melvin E.
- Bhattacharya, Sudin
- Bode, Johannes Georg
- Borner, Christoph
- Böttger, Jan
- Braeuning, Albert
- Budinsky, Robert A.
- Cameron, Neil R.
- Camussi, Giovanni
- Cho, Chong-Su
- Choi, Yun-Jaie
- Dahmen, Uta
- Damm, Georg
- Dirsch, Olaf
- Donato, María Teresa
- Dong, Jian
- Dooley, Steven
- Drasdo, Dirk
- Gibson, Andrew
- Glanemann, Matthias
- Groothuis, Geny M. M.
- Hallifax, David
- Hammad, Seddik
- Hayward, Adam
- Häussinger, Dieter
- Hellerbrand, Claus
- Hewitt, Philip
- Hoehme, Stefan
- Holzhütter, Hermann-Georg
- Houston, J. Brian
- Ito, Kiyomi
- Jaeschke, Hartmut
- Keitel, Verena
- Kordes, Claus
- Kullak-Ublick, Gerd A.
- LeCluyse, Edward L.
- Maltman, Daniel J.
- McMullen, Patrick
- Merfort, Irmgard
- Meyer, Christoph
- Mwinyi, Jessica
- Naisbitt, Dean J.
- Nussler, Andreas K.
- Olinga, Peter
- Pampaloni, Francesco
- Pi, Jingbo
- Pluta, Linda
- Przyborski, Stefan A.
- Ramachandran, Anup
- Rogiers, Vera
- Schwarz, Michael
- Singh, Bijay
- Stelzer, Ernst H. K.
- Stieger, Bruno
- Sugiyama, Yuichi
- Vanhaecke, Tamara
- Vinken, Mathieu
- Weiss, Thomas S.
- Woods, Courtney G.
- Hengstler, Jan G.
- Venue
- Archives of Toxicology
- Published
- 2013-08
- Volume
- 87
- Issue
- 8
- Pages
- 1315-1530
- ISSN
- 0340-5761 (ISSN-L)
- 1432-0738
- PMC
- PMC3753504
- OpenAlex
- W2134520937
- Cited by
- 1,280
- References
- 1,862
- Citations by year
- 2026: 54 · 2025: 63 · 2024: 59 · 2023: 80 · 2022: 98 · 2021: 96 · 2020: 130 · 2019: 132 · 2018: 129 · 2017: 102 · 2016: 118 · 2015: 110 · 2014: 91 · 2013: 12
- FWCI
- 18.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Archives of Toxicology (publishedVersion, other-oa)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- University of Regensburg Publication Server (University of Regensburg) (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- Durham Research Online (Durham University) (acceptedVersion, other-oa)
- Durham Research Online (Durham University) (submittedVersion, cc-by)
- HAL (submittedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- Repository of Digital Objects for Teaching Research and Culture (University of Valencia) (submittedVersion, cc-by-nc)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- University of Regensburg Publication Server (University of Regensburg)
- Funders
- Leibniz-Institut für Arbeitsforschung an der TU Dortmund
- Deutsche Forschungsgemeinschaft (GRK1104, (EXC 294))
- Agence Nationale de la Recherche
- Bundesministerium für Bildung und Forschung
- Belgian Federal Science Policy Office
- Fonds Wetenschappelijk Onderzoek
- National Research Foundation of Korea
- Innoviris
- Universität Regensburg
- Vlaamse regering
- National Institutes of Health (AA12916)
- Biotechnology and Biological Sciences Research Council (1233823)
- Leibniz-Gemeinschaft
- Japan Society for the Promotion of Science (23590204)
- National Institute on Alcohol Abuse and Alcoholism (R56AA012916, R01AA012916)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK070195)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Keywords
- hepatotoxicity, primary hepatocytes, non-parenchymal liver cells, hepatocyte co-culture, precision-cut liver slices, isolated perfused liver, stem cell-derived hepatocytes, induced pluripotent stem cell-derived hepatocytes, nuclear receptors, Ras/MEK/ERK pathway, HNF4α, drug metabolism, ADME, drug interactions
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Liver, Inactivation, Metabolic, Organ Culture Techniques, Signal Transduction, Receptors, Cytoplasmic and Nuclear, Toxicity Tests, Coculture Techniques, Hepatocytes, Toxicogenetics, Culture Techniques, High-Throughput Screening Assays
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review